Impact of methionine synthase gene and methylenetetrahydrofolate reductase gene polymorphisms on the risk of sudden sensorineural hearing loss

Audiology and Neurotology

Volumn 11, Issue 5, 2006, Pages 287-293

  Gross, Menachem ^a   Friedman, Gideon ^a   Eliashar, Ron ^a   Koren Morag, Nira ^b   Goldschmidt, Neta ^a   Atta, Iman Abou ^a   Ben Yehuda, Arie ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Methionine synthase; Methylenetetrahydrofolate reductase; Sudden sensorineural hearing loss; Vascular impairment

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); DNA FRAGMENT; HOMOCYSTEINE; METHIONINE SYNTHASE; RESTRICTION ENDONUCLEASE;

ADULT; AGED; ALLELE; ARTICLE; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DNA POLYMORPHISM; ELECTROPHORESIS; FEMALE; GENE; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; PERCEPTION DEAFNESS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SUDDEN DEAFNESS;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; ADULT; AGED; CASE-CONTROL STUDIES; COCHLEA; FEMALE; GENE FREQUENCY; GENOTYPE; HEARING LOSS, SENSORINEURAL; HEARING LOSS, SUDDEN; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; VASCULAR DISEASES;

EID: 33749364356     PISSN: 14203030     EISSN: 14219700     Source Type: Journal    
DOI: 10.1159/000093957     Document Type: Article

References (29)

1. Boushey CJ, Shirley A, Beresford A, Omenn GS, Motulsky AG: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease - probable benefits of increasing folic acid intakes. JAMA 1995;274:1049-1057.
2. Cadoni G, Agostino S, Scipione S, Galli J: Low folate levels: a risk factor for sudden sensorineural hearing loss? Acta Otolaryngol 2004;124:608-611.
3. Capaccio P, Ottaviani F, Cuccarini V, Ambrosetti U, Fagnani E, Bottero A, Cenzuales S, Cesana BM, Pignataro L: Sudden hearing loss and MTHFR 677C>T/1298A>C gene polymorphisms. Genet Med 2005;7:206-208.
4. Cole RR, Jahrsdoerfer RA: Sudden hearing loss: an update. Am J Otol 1988;9:211-215.
5. D'Angelo A, Coppola A, Madonna P, Fermo I, Pagano A, Mazzola G, Galli L, Cerbone AM: The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events. Thromb Haemost 2000;83:563-570.
6. Durrant JD, Lovrinic JH: Bases of Hearing Science. Baltimore, Williams & Wilkins, 1995, pp 102-137.
7. Feix A, Fritsche-Polanz R, Kletzmayr J, Vychytil A, Horl WH, Sunder-Plassmann G, Fodinger M: Increased prevalence of combined MTR and MTHFR genotypes among individuals with severely elevated total homocysteine plasma levels. Am J Kidney Dis 2001;38:956-964.
8. Friedman G, Goldschmidt N, Friedlander Y, Ben-Yehuda A, Selhub J, Babaey S, Mendel M, Kidron M, Bar-On H: A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations. J Nutr 1999;129:1656-1661.
9. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, Den Heijer M, Kluijtmans LA, Van den Heuvel LP, Rozen RA: Candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genet 1995;10:111-113.
10. Harmon DL, Shields DC, Woodside JV, McMaster D, Yarnell JW, Young IS, Peng K, Shane B, Evans AE, Whitehead AS: Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet Epidemiol 1999;17:298-309.
11. Hyndman ME, Bridge PJ, Warnica JW, Fick G, Parsons HG: Effect of heterozygosity for the methionine synthase 2756 A->G mutation on the risk for recurrent cardiovascular events. Am J Cardiol 2000;86:1144-1146.
12. Klerk M, Lievers KJ, Kluijtmans LA, Blom HJ, den Heijer M, Schouten EG, Kok FJ, Verhoef P: The 2756A>G variant in the gene encoding methionine synthase: its relation with plasma homocysteine levels and risk of coronary heart disease in a Dutch case-control study. Thromb Res 2003;110:87-91.
13. Leclerc D, Campeau E, Goyette P, Adjalla CE, Christensen B, Ross M, Eydoux P, Rosenblatt DS, Rozen R, Gravel RA: Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders. Hum Mol Genet 1996;5:1867-1874.
14. Ma J, Stampfer MJ, Christensen B, Giovannucci E, Hunter DJ, Chen J, Willett WC, Selhub J, Hennekens CH, Gravel R, Rozen R: A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 1999;8:825-829.
15. Morita H, Kurihara H, Sugiyama T, Hamada C, Kurihara Y, Shindo T, Oh-hashi Y, Yazaki Y: Polymorphism of the methionine synthase gene: association with homocysteine metabolism and late-onset vascular diseases in the Japanese population. Arterioscler Thromb Vasc Biol 1999;19:298-302.
16. Nagahara K, Fisch U, Yagi N: Perilymph oxygenationin sudden and progressive sensorineural hearing loss. Acta Otolaryngol 1983;96:57-68.
17. Nakamura M, Whitlock G, Aoki N, Nakashima T, Hoshino T, Yokoyama T, Morioka S, Kawamura T, Tanaka H, Hashimoto T, Ohno Y: Japanese and western diet and risk of idiopathic sudden deafness: a case-control study using pooled controls. Int J Epidemiol 2001;30:608-615.
18. Rudack C, Langer C, Junker R: Platelet GPIaC807T polymorphism is associated with negative outcome of sudden hearing loss. Hear Res 2004;191:41-48.
19. Salomon O, Rosenberg N, Zivelin A, Steinberg DM, Kornbrot N, Dardik R, Inbal A, Seligsohn U: Methionine synthase A2756G and methylenetetrahydrofolate reductase A1298C polymorphisms are not risk factors for idiopathic venous thromboembolism. Hematol J 2001;2:38-41.
20. Schuknecht HF, Kimura RS, Naufal PM: The pathology of sudden deafness. Acta Otolaryngol 1973;76:75-97.
21. Shipchandler MT, Moore EG: Rapid, fully automated measurement of plasma homocysteine with the Abbott IMx analyzer. Clin Chem 1995;41:991-994.
22. Song KS, Song JW, Choi JR, Kim HK, Shin JS, Kim JH: Homozygous V/V (677C to T) and D/D (2756G to A) variants in the methylene-tetrahydrofolate and methionine synthase genes in a case of hyperhomocysteinemia with stroke at young age. Exp Mol Med 2001;33:106-109.
23. Suckfüll M: Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial. Lancet 2002;360:1811-1817.
24. Suckfüll M, Thiery J, Schorn K, Kastenbauer E, Seidel D: Clinical utility of LDL-apheresis in the treatment of sudden hearing loss: a prospective, randomized study. Acta Otolaryngol 1999;119:763-766.
25. Suckfüll M, Wimmer C, Reichel O, Mees K, Schorn K: Hyperfibrinogenemia as a risk factor for sudden hearing loss. Otol Neurotol 2002;23:309-311.
26. Tsai MY, Welge BG, Hanson NQ, Bignell MK, Vessey J, Schwichtenberg K, Yang F, Bullemer FE, Rasmussen R, Graham KJ: Genetic causes of mild hyperhomocysteinemia in patients with premature occlusive coronary artery diseases. Atherosclerosis 1999;143:163-170.
27. Van der Put NM, Van der Molen EF, Kluijtmans LA, Heil SG, Trijbels JM, Eskes TK, Van Oppenraaij-Emmerzaal D, Banerjee R, Blom HJ: Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease. QJM 1997;90:511-517.
28. Wang XL, Cai H, Cranney G, Wilcken DEL: The frequency of a common mutation of the methionine synthase gene in the Australian population and its relation to smoking and coronary artery disease. J Cardiovasc Risk 1998;5:289-295.
29. Wang XL, Duarte N, Cai H, Adachi T, Sim AS, Cranney G, Wilcken DE: Relationship between total plasma homocysteine, polymorphisms of homocysteine metabolism related enzymes, risk factors and coronary artery disease in the Australian hospital-based population. Atherosclerosis 1999;146:133-140.